Brandinium

Trademark search for:

OSMOLEX

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2017-04-14 — Application filed
  • 2017-04-18 — Application filed
  • 2017-04-21 — Application filed
  • 2017-07-10 — Assigned to examiner
  • 2017-07-17 — Approved for pub - principal register
  • 2017-08-02 — Notification of notice of publication e-mailed
  • 2017-08-22 — Published for opposition
  • 2017-08-22 — Official gazette publication confirmation e-mailed
  • 2017-10-17 — Noa e-mailed - sou required from applicant
  • 2018-04-16 — Teas change of correspondence received
  • 2018-04-16 — Sou teas extension received
  • 2018-04-16 — Sou extension 1 filed
  • 2018-04-16 — Sou extension 1 granted
  • 2018-04-18 — Notice of approval of extension request e-mailed
  • 2018-10-11 — Sou teas extension received
  • 2018-10-11 — Sou extension 2 filed
  • 2018-10-11 — Sou extension 2 granted
  • 2018-10-13 — Notice of approval of extension request e-mailed
  • 2019-04-16 — Teas statement of use received
  • 2019-04-16 — Use amendment filed
  • 2019-04-27 — Case assigned to intent to use paralegal
  • 2019-04-27 — Statement of use processing complete
  • 2019-04-30 — Allowed principal register - sou accepted
  • 2019-05-01 — Notice of acceptance of statement of use e-mailed
  • 2019-06-04 — Registered-principal register
  • 2021-02-10 — Automatic update of assignment of ownership
  • 2021-10-06 — Automatic update of assignment of ownership
  • 2021-10-13 — Automatic update of assignment of ownership
  • 2021-12-01 — Teas change of owner address received
  • 2021-12-01 — Teas revoke/app/change addr of atty/dom rep received
  • 2021-12-01 — Attorney/dom.rep.revoked and/or appointed
  • 2021-12-01 — Teas change of correspondence received
  • 2021-12-01 — Applicant/correspondence changes (non-responsive) entered
  • 2022-01-19 — Assignment of ownership not updated automatically
  • 2022-01-19 — Assignment of ownership not updated automatically
  • 2022-01-19 — Assignment of ownership not updated automatically
  • 2022-06-23 — Assignment of ownership not updated automatically
  • 2022-06-23 — Assignment of ownership not updated automatically
  • 2022-06-23 — Assignment of ownership not updated automatically
  • 2024-03-18 — Teas change of owner address received
  • 2024-03-18 — Applicant/correspondence changes (non-responsive) entered
  • 2024-03-18 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-03-18 — Attorney/dom.rep.revoked and/or appointed
  • 2024-03-18 — Teas change of correspondence received
  • 2024-06-04 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2025-12-19 — Cancelled sec. 8 (6-yr)
  • 2025-12-19 — Final status recorded

Owner Information

ADAMAS PHARMA, LLC
Rockville , MD
ACELLA HOLDINGS, LLC
ALPHARETTA , GA
ADAMAS PHARMACEUTICALS, INC.
EMERYVILLE , CA
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság
Budapest HU
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság
Budapest HU
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelôsségû Társaság
Budapest HU

Correspondent

Mark D. Simpson Saul Ewing LLP
1500 Market Street
Centre Square West, 38th Floor
Philadelphia, PA 19102

Filing Details

Filing Date:
2017-04-14
Status Date:
2025-12-19
Category:
Pharmaceuticals
Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.